Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020.
Alm E, Broberg EK, Connor T, Hodcroft EB, Komissarov AB, Maurer-Stroh S, Melidou A, Neher RA, O'Toole Á, Pereyaslov D; WHO European Region sequencing laboratories and GISAID EpiCoV group; WHO European Region sequencing laboratories and GISAID EpiCoV group*. Alm E, et al. Euro Surveill. 2020 Aug;25(32):2001410. doi: 10.2807/1560-7917.ES.2020.25.32.2001410. Euro Surveill. 2020. PMID: 32794443 Free PMC article.
Development of an Inactivated Vaccine against SARS CoV-2.
Pavel STI, Yetiskin H, Uygut MA, Aslan AF, Aydın G, İnan Ö, Kaplan B, Ozdarendeli A. Pavel STI, et al. Among authors: aydin g. Vaccines (Basel). 2021 Nov 2;9(11):1266. doi: 10.3390/vaccines9111266. Vaccines (Basel). 2021. PMID: 34835197 Free PMC article.
Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials.
Ozdarendeli A, Sezer Z, Pavel STI, Inal A, Yetiskin H, Kaplan B, Uygut MA, Bayram A, Mazicioglu M, Unuvar GK, Yuce ZT, Aydin G, Aslan AF, Kaya RK, Koc RC, Ates I, Kara A. Ozdarendeli A, et al. Among authors: aydin g. Vaccine. 2023 Jan 9;41(2):380-390. doi: 10.1016/j.vaccine.2022.10.093. Epub 2022 Nov 22. Vaccine. 2023. PMID: 36460536 Free PMC article.
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up.
Sezer Z, Pavel STI, Inal A, Yetiskin H, Kaplan B, Uygut MA, Aslan AF, Bayram A, Mazicioglu M, Kalin Unuvar G, Yuce ZT, Aydin G, Kaya RK, Ates I, Kara A, Ozdarendeli A. Sezer Z, et al. Among authors: aydin g. Vaccines (Basel). 2024 Jan 29;12(2):140. doi: 10.3390/vaccines12020140. Vaccines (Basel). 2024. PMID: 38400124 Free PMC article.
Impact of vaccination on ICU admissions of hospitalized COVID-19 patients in a country with a heterologous vaccine policy.
Yıldırım S, Kirakli C, Özdemir Y, Tosun S, Ermin S, Polat G, Yılmaz C, Bilaçeroğlu S, Salık B, Kömürcüoğlu B, Ödemiş İ, Köse Ş, Uzun U, Aydın G, İlhan E. Yıldırım S, et al. Among authors: aydin g. J Infect Dev Ctries. 2024 Apr 30;18(4):513-519. doi: 10.3855/jidc.18342. J Infect Dev Ctries. 2024. PMID: 38728641 Free article.
283 results